108 related articles for article (PubMed ID: 17654326)
1. Influence of pretransplant IFN-alpha therapy on interstitial fibrosis in renal allografts with hepatitis C virus infection.
Ozdemir BH; Ozdemir FN; Sezer S; Haberal M
Ren Fail; 2007; 29(5):615-22. PubMed ID: 17654326
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Kamar N; Ribes D; Izopet J; Rostaing L
Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
[TBL] [Abstract][Full Text] [Related]
5. Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C.
Luciani G; Bossola M; Muscaritoli M; Panocchia N; Ferrante A; Nanni G; Piccioni E; Tazza L; Grillo RL; Rossi Fanelli F; Castagneto M
J Nephrol; 2003; 16(3):417-20. PubMed ID: 12832744
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis C virus infection in renal-transplant patients].
Kamar N; Izopet J; Ribes D; Rostaing L
Nephrologie; 2004; 25(1):9-15. PubMed ID: 15022868
[TBL] [Abstract][Full Text] [Related]
7. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
Terrault NA; Adey DB
Clin J Am Soc Nephrol; 2007 May; 2(3):563-75. PubMed ID: 17699464
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stellate cells in hepatitis C patients: relationship with the development of interstitial fibrosis in renal allografts.
Ozdemir BH; Bilezikçi B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2838-40. PubMed ID: 19765451
[TBL] [Abstract][Full Text] [Related]
9. Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts.
Wéclawiack H; Kamar N; Mehrenberger M; Guilbeau-Frugier C; Modesto A; Izopet J; Ribes D; Sallusto F; Rostaing L
Nephrol Dial Transplant; 2008 Mar; 23(3):1043-7. PubMed ID: 17913730
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection and outcome of renal transplantation.
Ridruejo E; Cusumano A; Diaz C; Dávalos Michel M; Jost L; Jost h L; Soler Pujol G; Mandó OG; Vilches A
Transplant Proc; 2007 Dec; 39(10):3127-30. PubMed ID: 18089337
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of hepatitis C virus infection in renal transplant recipients.
Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis C virus on renal transplantation: association with poor survival.
Pedroso S; Martins L; Fonseca I; Dias L; Henriques AC; Sarmento AM; Cabrita A
Transplant Proc; 2006; 38(6):1890-4. PubMed ID: 16908314
[TBL] [Abstract][Full Text] [Related]
13. Patient and graft survival of kidney allograft recipients with minimal hepatitis C virus infection: a case-control study.
Shahbazian H; Hajiani E; Ehsanpour A
Urol J; 2008; 5(3):178-83. PubMed ID: 18825625
[TBL] [Abstract][Full Text] [Related]
14. Outcome of renal allograft in Turkish patients with pretransplantation hepatitis C virus infection.
Unal E; Turkmen F; Sevinc C; Kiziler AR; Aydemir B; Titiz I
Transplant Proc; 2006 Dec; 38(10):3448-50. PubMed ID: 17175299
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
[TBL] [Abstract][Full Text] [Related]
16. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
17. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
Minz M; Sharma A; Das A; Chawla Y
Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in haemodialysis and kidney transplant patients.
Baid-Agrawal S; Pascual M; Moradpour D; Frei U; Tolkoff-Rubin N
Rev Med Virol; 2008; 18(2):97-115. PubMed ID: 18064722
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
Nanmoku K; Imaizumi R; Tojimbara T; Nakajima I; Fuchinoue S; Sakamoto N; Watanabe M; Teraoka S
Transplant Proc; 2008 Sep; 40(7):2382-5. PubMed ID: 18790241
[TBL] [Abstract][Full Text] [Related]
20. Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts.
Yelken B; Gorgulu N; Caliskan Y; Elitok A; Cimen AO; Yazici H; Oflaz H; Turkmen A; Sever MS
Transplant Proc; 2009 Jun; 41(5):1519-23. PubMed ID: 19545669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
